Additional Measures After Stopping Nucleoside Analogues in HbeAg-Negative Chronic Hepatitis B: Better But Not Enough

被引：0
|
作者：
Lim, Seng gee [1 ,3 ]
Tan, Yong chuan [2 ]
机构：
[1] Natl Univ Singapore, Natl Univ Hlth Syst, Div Gastroenterol & Hepatol, Dept Med, Singapore, Singapore
[2] Natl Univ Hlth Syst, Div Gastroenterol & Hepatol, Dept Med, Singapore, Singapore
[3] Natl Univ Singapore Hosp, Dept Gastroenterol & Hepatol, 1E Lower Kent Ridge Rd, Singapore 119228, Singapore
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 01期
基金：
英国医学研究理事会;
关键词：
CESSATION; HBSAG;
D O I：
10.1053/j.gastro.2023.10.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [31] Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B
    Papatheodoridis, George V.
    Manolakopoulos, Spilios
    Su, Tung-Hung
    Siakavellas, Spyros
    Liu, Chun-Jen
    Kourikou, Anastasia
    Yang, Hung-Chih
    Kao, Jia-Horng
    HEPATOLOGY, 2018, 68 (02) : 415 - 424
  • [32] Letter to the Editor: Retreatment Decision for Hepatitis B Flare in HBeAg-Negative Chronic Hepatitis B
    Kumar, Karan
    Dixit, Indresh
    HEPATOLOGY, 2021, 73 (05) : 2081 - 2082
  • [33] Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
    Papatheodoridis, George V.
    LIVER INTERNATIONAL, 2013, 33 : 151 - 156
  • [34] Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    Tiniakos, Dina G.
    Hadziyannis, Emilia S.
    Agelopoulou, Olga P.
    Syminelaki, Thalia
    Papaioannou, Christos
    Nastos, Theodoros
    Karayiannis, Peter
    JOURNAL OF HEPATOLOGY, 2011, 55 (01) : 61 - 68
  • [35] Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial
    Enomoto, Masaru
    Tamori, Akihiro
    Kohmoto, Madoka Toyama
    Hayashi, Takehiro
    Morikawa, Hiroyasu
    Jomura, Hisato
    Sakaguchi, Hiroki
    Habu, Daiki
    Kawada, Norifumi
    Shiomi, Susumu
    Nishiguchi, Shuhei
    HEPATOLOGY RESEARCH, 2008, 38 (09) : 954 - 959
  • [36] HbeAg-negative chronic hepatitis B results in more severe liver disease than HBeAg-positive chronic hepatitis B
    Mahtab, M.
    Rahman, S.
    Khan, M.
    LIVER INTERNATIONAL, 2006, 26 : 55 - 55
  • [37] Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
    zu Siederdissen, Christoph Hoener
    Rinker, Franziska
    Maasoumy, Benjamin
    Wiegand, Steffen B.
    Filmann, Natalie
    Falk, Christine S.
    Deterding, Katja
    Port, Kerstin
    Mix, Carola
    Manns, Michael P.
    Herrmann, Eva
    Wedemeyer, Heiner
    Kraft, Anke R. M.
    Cornberg, Markus
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (10): : 1492 - 1497
  • [38] Prevalence of HBeAg-negative chronic hepatitis in Benghazi, Libya
    Zouki, A.
    Belkhair, S.
    Tumi, A.
    LIVER INTERNATIONAL, 2006, 26 : 52 - 52
  • [39] Role of hepatosteatosis in HBsAg seroconversion in HBeAg-negative chronic hepatitis B patients
    Bacaksiz, Ferhat
    Gokcan, Hale
    Akdogan, Meral
    Gokce, Dilara Turan
    Ari, Derya
    Gokbulut, Volkan
    Ergun, Yakup
    Ozturk, Omer
    Kacar, Sabite
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)
  • [40] Long term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Bhushan, B.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S95 - S95
12345